CVE-2020-3227

Cisco IOx for IOS XE Software Privilege Escalation Vulnerability

Description

A vulnerability in the authorization controls for the Cisco IOx application hosting infrastructure in Cisco IOS XE Software could allow an unauthenticated, remote attacker to execute Cisco IOx API commands without proper authorization. The vulnerability is due to incorrect handling of requests for authorization tokens. An attacker could exploit this vulnerability by using a crafted API call to request such a token. An exploit could allow the attacker to obtain an authorization token and execute any of the IOx API commands on an affected device.

Categories

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 18.04% Top 10%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software 16.3.1
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-3227?
CVE-2020-3227 has been scored as a critical severity vulnerability.
How to fix CVE-2020-3227?
To fix CVE-2020-3227, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-3227 being actively exploited in the wild?
It is possible that CVE-2020-3227 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~18% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-3227?
CVE-2020-3227 affects Cisco Cisco IOS XE Software 16.3.1.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.